These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 17610945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
    Zhang XZ.
    Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. How is pluripotency determined and maintained?
    Niwa H.
    Development; 2007 Feb; 134(4):635-46. PubMed ID: 17215298
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA.
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
    Kawazoe S, Ikeda N, Miki K, Shibuya M, Morikawa K, Nakano S, Oshimura M, Hisatome I, Shirayoshi Y.
    Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
    [Abstract] [Full Text] [Related]

  • 15. Chicken embryonic stem cells as a non-mammalian embryonic stem cell model.
    Lavial F, Pain B.
    Dev Growth Differ; 2010 Jan; 52(1):101-14. PubMed ID: 20039925
    [Abstract] [Full Text] [Related]

  • 16. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G.
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [Abstract] [Full Text] [Related]

  • 17. Natural and artificial routes to pluripotency.
    Krueger WH, Swanson LC, Tanasijevic B, Rasmussen TP.
    Int J Dev Biol; 2010 Oct; 54(11-12):1545-64. PubMed ID: 21404178
    [Abstract] [Full Text] [Related]

  • 18. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
    Atkinson S, Armstrong L.
    Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
    [Abstract] [Full Text] [Related]

  • 19. Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches.
    Li W, Ding S.
    Methods Mol Biol; 2010 Jan; 636():293-300. PubMed ID: 20336530
    [Abstract] [Full Text] [Related]

  • 20. Basic FGF and Activin/Nodal but not LIF signaling sustain undifferentiated status of rabbit embryonic stem cells.
    Honda A, Hirose M, Ogura A.
    Exp Cell Res; 2009 Jul 15; 315(12):2033-42. PubMed ID: 19331817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.